FDA Inspection 816496 — Biomat USA Inc

Biomat USA Inc — FEI 1000522112

The FDA completed an inspection of Biomat USA Inc on January 31, 2013 in Cleveland, OH. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
January 31, 2013
Fiscal Year
2013
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Cleveland, OH (United States)

Citations

IDCFRDescription
922521 CFR 606.171Biological product deviation report